Table 5.
Whole Blood Clinical Chemistry Markers for the Placebo and NO-Shotgun Groups at Days 0 and 29.
| Variable | PL Day 0 | PL Day 29 | NO Day 0 | NO Day 29 |
| WBC (K/μl) | 6.10 (1.28) | 5.81 (1.35) | 5.09 (1.25) | 5.37 (2.06) |
| RBC (M/μL) | 5.09 (0.29) | 5.27 (0.42) | 4.74 (0.26) | 4.68 (0.23) |
| Hemoglobin (g/gl) | 15.35 (1.04) | 16.08 (1.36) | 14.60 (0.68) | 14.46 (0.53) |
| Hematocrit (%) | 46.36 (1.92) | 48.17 (3.29) | 43.41 (1.70) | 42.91(1.26) |
| MCV (fl) | 91.11 (1.90) | 91.46 (1.81) | 91.67 (3.00) | 91.90 (4.39) |
| MCH (pg) | 30.13 (1.00) | 30.50 (0.81) | 30.80 (1.29) | 30.91 (1.56) |
| MCHC (g/dl) | 33.10 (1.15) | 33.37 (1.03) | 33.61 (0.59) | 33.62 (0.29) |
| Lymphocytes (K/μl) | 2.07 (0.26) | 1.86 (0.43) | 1.89 (0.44) | 1.54 (0.34) |
| Monocytes (K/μl) | 0.46 (0.15) | 0.45 (0.21) | 0.27 (0.21) | 0.48 (0.24) |
| Neutrophils (K/μl) | 3.34 (1.11) | 3.19 (1.15) | 2.67 (0.90) | 3.02 (2.10) |
| Eosinophils (K/μl) | 0.22 (0.18) | 0.23 (0.17) | 0.15 (0.11) | 0.24 (0.14) |
| Basophils (K/μl) | 0.06 (0.05) | 0.06 (0.02) | 0.07 (0.04) | 0.07 (0.04) |
Data are presented as means and standard deviations. No significant differences were observed with resistance training or between groups throughout the 28-day study for whole blood clinical chemistry variables (p > 0.05).